Industry Chapter
Dr Tan Chong Kiat 
Chairman
Chong Kiat is a Scientist in the Analytical R&D Department at Procter & Gamble Singapore Innovation Centre. He is in charge of the study of colloid phases in hair and skincare products via thermal analysis, rheology and in-line process analytical tools.
Prior to joining Procter & Gamble, he was a Senior Member of Technical Staff at ATREC Pte Ltd. He applied his organic synthesis training to making and study of various defence related materials.
Chong Kiat obtained his PhD from the National University of Singapore making contributions to the field of organocatalytic asymmetric halogenation of alkenes. He also studied the use of polymer supports for solid-phase organic synthesis of various nitrogen-containing carbon heterocycles. Both studies have resulted in over 20 publications.
Dr Shu Ann
co-Chairman
Shu Ann is an Innovation Manager, Biotech Platform Architect at National Health Innovation Centre Singapore (NHIC).
In her current role as an innovation manager, she manages innovation projects and provides strategic guidance to these project teams to enable the commercial translation of institutional R&D projects. Besides managing innovation projects, Shu Ann has also been involved in developing national-level programs that foster innovation and enterprise activities in the healthcare and biomedical field. Her interest lies in health/biotech venture creation and venture building.
Prior to joining NHIC, Shu Ann held a postdoctoral position developing small molecule and peptide inhibitors against Dengue/Zika non-structural proteins. She obtained her PhD from the Australian National University (ANU), where she specialized in Protein and Enzyme Engineering.
Miss Esther Loh Wei Tian
Secretary
Esther is a Manager at Deloitte & Touche Financial Advisory Services Pte Ltd and was recognized as one of the leading intellectual property (IP) strategists in IAM 300.
Previously, she was an IP Management Consultant at IP ValueLab, an enterprise engagement arm of the Intellectual Property Office of Singapore. In addition, she was with a technology transfer office, managing more than 500 IPs from national research institutes.
Before joining the IP industry, she was a researcher at a multinational company where she translated the technologies of her own led projects to potential products for the market. She has 12 patent families under her name as co-inventor.
Esther obtained her Masters and her BSc (Honours) in Chemistry from the National University of Singapore.
Dr Wei Ying
Member
Wei Ying is Director of Clinical Affairs, Esco Ventures Pte Ltd. She has extensive experience in scientific research, medical affairs, clinical studies and health products registration and launches in the Asia Pacific region, across a wide range of disease and health benefit areas. She has developed an expert knowledge of Good Clinical Practice application, strategic clinical trial planning and execution, and clinical program quality management. She developed, established, and maintained good relations with research institutes in APAC.
Wei Ying obtained her PhD in Chemistry specializing in the area of Food Science & Nutrition from the National University of Singapore, and postdoctoral training in the Department of Obstetrics and Gynaecology, National University Hospital. She received her MD from Guangxi Medical University and practised in China.
Esther obtained her Masters and her BSc (Honours) in Chemistry from the National University of Singapore.
Miss Low Chang Yee
Member
Since graduating from NUS in 2012 with a BSc in Applied Science (Chemistry), Chang Yee has accumulated some research experience while working in NTU. She then went on to explore areas outside of academia, working in a start-up that provides safety and efficacy studies for pharmaceuticals and cosmetics. She now works in a pharmaceutical contract drug manufacturing organization. Joining this chapter, she hopes to learn more from experienced industry professionals, while paying it forward to assist individuals who would like to embark on a career in Chemistry. She holds a Graduate Certificate in Drug Development from Temple University and an Advanced Certificate in Training and Assessment from the Institute of Adult Learners.
Dr Filza Aslam
Member
Trained as a synthetic organic chemist, Filza holds a PhD from Nanyang Technological University. She carried out her doctoral studies in collaboration with the Novartis Institute for Tropical Diseases, where she focused her research on discovering solutions to access novel compounds with potent antimalarial activity. Since completing her Ph.D., Filza's experience ranges from medical affairs to market access and clinical research in both the pharma and MedTech space. She recently joined J&J as a Medical Science Liaison, looking after the multiple myeloma portfolio.
Alumni
Dr Fu Xiao
Treasurer
Fu Xiao joined BASF as a research scientist and was in charge of various research projects in different industrial applications. His expertise includes the water treatment, antimicrobial treatment and oilfield chemicals. Fu Xiao joined Nalco Champion, An Ecolab Company in 2017 to focus on his research application in oilfield chemicals.
Fu Xiao obtained his PhD in Chemistry from the National University of Singapore and his Bachelor degree from Peking University, China. During his PhD study, his research topic was the organocatalyst catalysed asymmetric synthesis. He published more than ten papers and one patent as first author and co-author. He was awarded the Reaxys PhD Prize in 2010, which is the leading prize for PhD students in chemistry around the globe.
Dr Yuan Ming Jun
Member
Ming Jun is currently working as a principal engineer at EMK Technologies. His current research covers R&D of industrial speciality chemicals, formulations of a novel or customised special chemicals for semiconductors usage. Since 2016, he is erving as an adjunct research scientist at the Division of Chemitry of Biologicial Chemistry, Nanyang Technological Univeristy.
Ming Jun obtained his PhD in chemistry in 2010 from Nanyang Technological University. Upon graduation, he joined STATS ChipPAC Ltd, a wafer-level packaging company as a senior process engineer. in 2012, he joined Nanyang Technological University and Singapore Centre for Environmental Life Sciences Engineering as a research fellow in the area of organic and medicinal chemistry.
Dr Joe Zhao Yu Jun Member
Joe obtained his PhD in Chemistry from the National University of Singapore and his Master degree in Chemistry from Chinese Academy of Sciences. After graduated from NUS, Joe joined the Institute of Materials Research and Engineering (IMRE), A*STAR., Singapore.
Then he started to work as Chief Operating Officer in EASYGO PTE LTD and AION SCIENTIFIC PTE LTD. EASYGO is a professional Travel Agency, EASYGO PTE LTD is a company which specialises in free & Easy travel, Group travel, Luxury tour packages for our clients. It also provides hotel booking, air tickets booking, local attraction ticket purchase and other related services.
AION SCIENTIFIC PTE LTD is a Singapore based company, as a service distributor of equipment, glassware, consumables and research chemicals for local and regional research laboratories. AION SCIENTIFIC dedicates us exclusively to supporting our customers in the fields of Chemistry, Materials, Life Science, Pharmaceuticals and Food and Agriculture.
Dr James Wang Jian Min
Chairman
James is national sales manager for Procter & Gamble Chemicals Greater China & South Korea. He is responsible for oleochemicals total Go-To-Market Strategy in the above-mentioned markets. He owns the Revenue and Profitability target of Procter & Gamble Chemicals. He is a Procter & Gamble “The CEO Award” winner. The CEO Award is given to only 3% of the total Procter & Gamble employees.
James obtained his PhD in Chemistry from the National University of Singapore and obtained a Master’s degree from Beijing University of Chemical Technology. His research focuses on organocatalyst catalyzed asymmetric synthesis & synthesis, and Characterization of helical polymers & co-polymers.
Dr Wendy Leong Wen Yi Chairman
Wendy is an Intellectual Property Specialist at ResMed, a company that helps people stay out of the hospital, thereby empowering them to live healthier, higher-quality lives. She supports the Oxygen Product Development team of ResMed in IP-related matters. Prior to joining ResMed, she was at a boutique IP law firm where she advised clients on their patent filing strategy, drafted patent specifications and assisted in worldwide prosecution of patent applications
Wendy obtained her PhD in Chemistry from the Nanyang Technological University and her BSc (Honours) in Chemistry from the National University of Singapore. She is a co-author of 11 research articles in top international peer-reviewed journals, which include Nature Chemistry, the Journal of the American Chemical Society, and Green Chemistry. Due to her contributions to the development of a green chemistry technology which was recognised to prevent pollution and have broad applicability in industry, she was awarded the Presidential Green Chemistry Challenge Award by the Environmental Protection Agency, USA, in 2011.
Dr Jie An Yang
co-Chairman
Jie An is a Trainee Patent Attorney within the chemistry/life-sciences group of Davies Collison Cave, where he is involved in the preparation and prosecution of patent applications in pharmaceutical sciences, nanotechnology and material sciences.
Jie An has a research background in pharmacokinetics, inorganic chemistry, nanotechnology and polymer sciences. He obtained his BSc (Honours) degree in Chemistry at the National University of Singapore and moved on to obtain his PhD in Chemistry at the University of Illinois at Urbana Champaign. During his PhD studies, his work centred on investigating the interaction of nanoparticles at the biomolecular and cellular level, ultimately cumulating in the publication in several peer-reviewed scientific journals.
Prior to joining Davies Collison Cave, Jie An spent about two years at Mitsui Chemicals doing polymer research, exploring the marketability and applications of propriety technologies.